Indications -- Psoriasis/Chronic Inflammation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Indications -- Psoriasis/Chronic Inflammation

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Icebrg who wrote (275)	9/23/2002 9:01:15 AM
From: scaram(o)uche	Read Replies (2) of 631

They seem, to me, to be terribly sloppy when describing this antibody. What is the mechanism? Anti-CD4 as a therapeutic has been of interest since the days of Noel Warner and BD's therapeutic program. What makes this effort different? There is tons of data saying that epitope selection might be important, but nobody has made it stick re. data on human cells, IMO. Is there any sophistication here?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next